tirzepatide use Mounjaro Injection Tirzepatide Dual Agonist (GLP-1/GIP) |

These data were first presented by Nakul Ganju, MD, of Howard University Hospital, Washington, DC, at the 2026 Crohns and Colitis Congress on Friday, January 23, 2026, in Las Vegas, Nevada

What if I miss a dose

however, these symptoms were mild to moderate in their intensity and were most often reported during dose escalation

Its especially helpful for individuals with low B12 levels due to stress, aging, or dietary limitations

PMID: 2315960 Zalups RK

Review: soluble innate immune pattern-recognition proteins for clearing dying cells and cellular components: implications on exacerbating or resolving inflammation